These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26197318)

  • 1. NOS1AP O-GlcNAc Modification Involved in Neuron Apoptosis Induced by Excitotoxicity.
    Zhu L; Tao T; Zhang D; Liu X; Ke K; Shen A
    Int J Mol Sci; 2015 Jul; 16(7):16560-75. PubMed ID: 26197318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc Glycosylation of nNOS Promotes Neuronal Apoptosis Following Glutamate Excitotoxicity.
    Chen R; Gong P; Tao T; Gao Y; Shen J; Yan Y; Duan C; Wang J; Liu X
    Cell Mol Neurobiol; 2017 Nov; 37(8):1465-1475. PubMed ID: 28238085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models.
    Li LL; Melero-Fernandez de Mera RM; Chen J; Ba W; Kasri NN; Zhang M; Courtney MJ
    J Neurosci; 2015 May; 35(19):7349-64. PubMed ID: 25972165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability.
    Lee WH; Carey LM; Li LL; Xu Z; Lai YY; Courtney MJ; Hohmann AG
    Mol Pain; 2018; 14():1744806918801224. PubMed ID: 30157705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of O-linked beta-N-acetylglucosamine modification sites in key contractile proteins of rat skeletal muscle.
    Hédou J; Bastide B; Page A; Michalski JC; Morelle W
    Proteomics; 2009 Apr; 9(8):2139-48. PubMed ID: 19322778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death.
    Li LL; Ginet V; Liu X; Vergun O; Tuittila M; Mathieu M; Bonny C; Puyal J; Truttmann AC; Courtney MJ
    J Neurosci; 2013 May; 33(19):8185-201. PubMed ID: 23658158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel post-translational modification in nerve terminals: O-linked N-acetylglucosamine phosphorylation.
    Graham ME; Thaysen-Andersen M; Bache N; Craft GE; Larsen MR; Packer NH; Robinson PJ
    J Proteome Res; 2011 Jun; 10(6):2725-33. PubMed ID: 21500857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-GlcNAc: a regulatory post-translational modification.
    Wells L; Whelan SA; Hart GW
    Biochem Biophys Res Commun; 2003 Mar; 302(3):435-41. PubMed ID: 12615051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3.
    Fong JJ; Nguyen BL; Bridger R; Medrano EE; Wells L; Pan S; Sifers RN
    J Biol Chem; 2012 Apr; 287(15):12195-203. PubMed ID: 22371497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosolic O-glycosylation is abundant in nerve terminals.
    Cole RN; Hart GW
    J Neurochem; 2001 Dec; 79(5):1080-9. PubMed ID: 11739622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.
    Wells L; Vosseller K; Cole RN; Cronshaw JM; Matunis MJ; Hart GW
    Mol Cell Proteomics; 2002 Oct; 1(10):791-804. PubMed ID: 12438562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tools for probing and perturbing O-GlcNAc in cells and in vivo.
    Cecioni S; Vocadlo DJ
    Curr Opin Chem Biol; 2013 Oct; 17(5):719-28. PubMed ID: 23906602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner.
    Svane KC; Asis EK; Omelchenko A; Kunnath AJ; Brzustowicz LM; Silverstein SM; Firestein BL
    Mol Cell Neurosci; 2018 Jun; 89():20-32. PubMed ID: 29601869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of nNOS-NOS1AP protein-protein interactions suppresses neuropathic pain in mice.
    Lee WH; Li LL; Chawla A; Hudmon A; Lai YY; Courtney MJ; Hohmann AG
    Pain; 2018 May; 159(5):849-863. PubMed ID: 29319606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
    Zachara NE; Cheung WD; Hart GW
    Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics.
    Khidekel N; Ficarro SB; Clark PM; Bryan MC; Swaney DL; Rexach JE; Sun YE; Coon JJ; Peters EC; Hsieh-Wilson LC
    Nat Chem Biol; 2007 Jun; 3(6):339-48. PubMed ID: 17496889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the reliability of computational O-GlcNAc prediction.
    Jochmann R; Holz P; Sticht H; Stürzl M
    Biochim Biophys Acta; 2014 Feb; 1844(2):416-21. PubMed ID: 24332980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
    Park SY; Ryu J; Lee W
    Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does O-GlcNAc play a role in neurodegenerative diseases?
    Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
    Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of NOS1AP with the NOS-I PDZ domain: Implications for schizophrenia-related alterations in dendritic morphology.
    Candemir E; Kollert L; Weißflog L; Geis M; Müller A; Post AM; O'Leary A; Harro J; Reif A; Freudenberg F
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):741-55. PubMed ID: 26861996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.